Cargando…
COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles
Among the co-infectious agents in COVID-19 patients, Aspergillus species cause invasive pulmonary aspergillosis (IPA). IPA is difficult to diagnose and is associated with high morbidity and mortality. This study is aimed at identifying Aspergillus spp. from sputum and tracheal aspirate (TA) samples...
Autores principales: | Ozturk, Ali, Bozok, Taylan, Erdogan, Merve, Ibrahim, Bashar MS., Bozok, Tugce Simsek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250855/ https://www.ncbi.nlm.nih.gov/pubmed/37294497 http://dx.doi.org/10.1007/s12223-023-01069-5 |
Ejemplares similares
-
COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021) -
Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA
por: Cocio, Tiago Alexandre, et al.
Publicado: (2023) -
P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship
por: Hawkins, Lois, et al.
Publicado: (2022) -
Evaluation of amino acid profile in serum of patients with Covid-19 for providing a new treatment strategy
por: Ozturk, Ali, et al.
Publicado: (2022) -
Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022)